Clinical Trials at Emory University

As of July 2026, 182 paid clinical trials are recruiting at Emory University, located at 1364 CLIFTON RD NE, ATLANTA, GA 30322-1064, phone (404) 686-7041 in Atlanta, Georgia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

184 clinical trials at Emory University

·Clear filters·↓ Download CSV

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for KRAS Altered Advanced or Metastatic Solid Tumors

Sites in Atlanta +9 more locations

Sponsor: Amgen

Sex: All·Age: 18+

Code: NCT07094113·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

BoxX-NoAF Clinical Trial

for Post Operative Atrial Fibrillation

Sites in Atlanta, Marietta +22 more locations

Sponsor: AtriCure, Inc.

Sex: All·Age: 65+·Accepts healthy volunteers

Code: NCT06989775·Recruiting·Listed May 2025

Apply to this trial

Study of COYA 302 for the Treatment of ALS

for Amyotrophic Lateral Sclerosis (ALS)

Sites in Atlanta +20 more locations

Sponsor: Coya Therapeutics

Sex: All·Age: 18 - 80

Code: NCT07161999·Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

for Extensive Stage Small Cell Lung Cancer

Drug: Tarlatamab

Sites in Atlanta +12 more locations

Sponsor: Amgen

Sex: All·Age: 18 - 90

Code: NCT07037758·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

for Immune Thrombocytopenic Purpura (ITP)

Sites in Atlanta +15 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06948318·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

for Neoplasms

Sites in Atlanta +10 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06150157·Phase 1·Recruiting·Listed Nov 2023

Apply to this trial

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

for Immune Thrombocytopenic Purpura (ITP)

Sites in Atlanta +16 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06722235·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

The PERSEVERE Study

for Pulmonary Embolism

Sites in Atlanta +14 more locations

Sponsor: Inari Medical

Sex: All·Age: 18+

Code: NCT06588634·Recruiting·Listed Sep 2024

Apply to this trial

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

for Crohn's Disease

Drug: Guselkumab

Sites in Atlanta +11 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 2 - 17

Code: NCT05923073·Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

for Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Sites in Atlanta +15 more locations

Sponsor: Electra Therapeutics Inc.

Sex: All·Age: 6+

Code: NCT05416307·Phase 2, Phase 3·Recruiting·Listed Jun 2022

Apply to this trial

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

for Crohn's Disease

Sites in Atlanta +14 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 2 - 17

Code: NCT05509777·Phase 3·Recruiting·Listed Aug 2022

Apply to this trial

A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment

for Homocystinuria

Sites in Atlanta +12 more locations

Sponsor: Travere Therapeutics, Inc.

Sex: All·Age: 12 - 65

Code: NCT06247085·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

for Regional Citrate Anticoagulation (RCA)

Sites in Atlanta +7 more locations

Sponsor: Vantive Health LLC

Sex: All·Age: 18+

Code: NCT05399537·Phase 3·Recruiting·Listed Jun 2022

Apply to this trial

Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

for Vasculitis

Drug: Rituximab

Sites in Atlanta +9 more locations

Sponsor: Amgen

Sex: All·Age: 6 - 17

Code: NCT06321601·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

for Pancreatic Cancer

Sites in Atlanta +12 more locations

Sponsor: Alpha Tau Medical LTD.

Sex: All·Age: 18 - 120

Code: NCT06698458·Recruiting·Listed Nov 2024

Apply to this trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

for Squamous Cell Carcinoma

Sites in Atlanta +9 more locations

Sponsor: Alpha Tau Medical LTD.

Sex: All·Age: 18+

Code: NCT06615635·Recruiting·Listed Sep 2024

Apply to this trial

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Sites in Atlanta +12 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06798012·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

for Systemic Lupus Erythematosus

Sites in Atlanta +18 more locations

Sponsor: Cabaletta Bio

Sex: All·Age: 18 - 65

Code: NCT06121297·Phase 1, Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

for Peripheral T-Cell Lymphoma, Not Otherwise Specified

Drug: Soquelitinib

Sites in Atlanta +20 more locations

Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT06561048·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

for Phenylketonuria (PKU)

Sites in Atlanta +11 more locations

Sponsor: BioMarin Pharmaceutical

Sex: All·Age: All ages

Code: NCT05813678·Recruiting·Listed Apr 2023

Apply to this trial

A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)

for Phenylketonuria (PKU)

Sites in Atlanta +10 more locations

Sponsor: BioMarin Pharmaceutical

Sex: All·Age: All ages

Code: NCT06305234·Recruiting·Listed Mar 2024

Apply to this trial

The JenaValve ALIGN-AR LVAD Registry

for Aortic Regurgitation

Sites in Atlanta +14 more locations

Sponsor: JenaValve Technology, Inc.

Sex: All·Age: 18+

Code: NCT06594705·Recruiting·Listed Sep 2024

Apply to this trial

A Global Prospective Observational Registry of Patients With Pompe Disease

for Pompe Disease

Sites in Atlanta +14 more locations

Sponsor: Amicus Therapeutics

Sex: All·Age: All ages

Code: NCT06121011·Recruiting·Listed Nov 2023

Apply to this trial

A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF

for Cystic Fibrosis

Sites in Atlanta +12 more locations

Sponsor: ReCode Therapeutics

Sex: All·Age: 18 - 60·Accepts healthy volunteers

Code: NCT06237335·Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

for Viral Pneumonia

Sites in Atlanta +21 more locations

Sponsor: Synairgen Research Ltd.

Sex: All·Age: 18+

Code: NCT06999603·Phase 2·Recruiting·Listed May 2025

Apply to this trial

TVMR With the INNOVALVE System Trial - Early Feasibility Study

for Mitral Valve Regurgitation (Degenerative or Functional)

Sites in Atlanta +18 more locations

Sponsor: Edwards Lifesciences

Sex: All·Age: 18+

Code: NCT04919980·Recruiting·Listed Jun 2021

Apply to this trial

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

for Stargardt

Sites in Atlanta +13 more locations

Sponsor: Splice Bio

Sex: All·Age: 12 - 65

Code: NCT06435000·Recruiting·Listed May 2024

Apply to this trial

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

for AML With Gene Mutations

Sites in Atlanta +11 more locations

Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All·Age: 18+

Code: NCT06366789·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

for Systemic Lupus Erythematosus

Sites in Atlanta +15 more locations

Sponsor: Zenas BioPharma (USA), LLC

Sex: All·Age: 18 - 70

Code: NCT06559163·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

for Coronary Artery Disease

Sites in Atlanta +16 more locations

Sponsor: Kardion Inc

Sex: All·Age: 18 - 90

Code: NCT06445608·Recruiting·Listed Jun 2024

Apply to this trial

InSpace Accelerated Rehabilitation Study

for Rotator Cuff Tears

Sites in Atlanta +10 more locations

Sponsor: Stryker Endoscopy

Sex: All·Age: 65+·Accepts healthy volunteers

Code: NCT05329584·Recruiting·Listed Apr 2022

Apply to this trial

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Drug: Teclistamab

Sites in Atlanta +10 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07518186·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

for Squamous Cell Carcinoma of Head and Neck

Sites in Atlanta +8 more locations

Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All·Age: 18 - 74

Code: NCT07219212·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

for Progressive Metastatic Castrate Resistant Prostate Cancer

Drug: Tulmimetostat

Sites in Atlanta +6 more locations

Sponsor: Novartis Pharmaceuticals

Sex: Male·Age: 18+

Code: NCT07206056·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

for Sickle Cell Disease

Sites in Atlanta, Augusta +5 more locations

Sponsor: Disc Medicine, Inc

Sex: All·Age: 18+

Code: NCT07187973·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

for Crohns Disease

Drug: Guselkumab

Sites in Atlanta +4 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 3+

Code: NCT06663332·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment

for IDH1-Mutated Malignancies

Sites in Atlanta +1 more location

Sponsor: Servier Bio-Innovation LLC

Sex: All·Age: 18+

Code: NCT07006688·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

for Breast Cancer

Sites in Atlanta +6 more locations

Sponsor: Regor Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT05304962·Phase 1·Recruiting·Listed Mar 2022

Apply to this trial

Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease

for IgG4 Related Disease

Sites in Atlanta +1 more location

Sponsor: Acepodia Biotech, Inc.

Sex: All·Age: 18 - 75

Code: NCT07061938·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

for NMIBC

Sites in Atlanta +8 more locations

Sponsor: ImmunityBio, Inc.

Sex: All·Age: 18 - 85

Code: NCT06800963·Phase 1, Phase 2·Recruiting·Listed Jan 2025

Apply to this trial